Human models for in vivo and in vitro assessment of topical antifungal compounds.
D000935:Antifungal Agents / Q000627:therapeutic use*; D003497:Cyclic N-Oxides / Q000627:therapeutic use; D006801:Humans; D066298:In Vitro Techniques; D008954:Models, Biological; D010647:Phenyl Ethers / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D012867:Skin / Q000382:microbiology; D013438:Sulfhydryl Compounds / Q000627:therapeutic use; D013827:Thiabendazole / Q000627:therapeutic use; D013997:Time Factors; D014005:Tinea / Q000188:drug therapy*; D014047:Tolnaftate / Q000627:therapeutic use; D014249:Trichophyton / Q000187:drug effects*
D000935:Antifungal Agents; D003497:Cyclic N-Oxides; D010647:Phenyl Ethers; D011725:Pyridines; D013438:Sulfhydryl Compounds; D014047:Tolnaftate; D013827:Thiabendazole